Counterpart Assistant (CA)
Search documents
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
Globenewswire· 2026-01-12 13:30
Counterpart continues to demonstrate that unified data and real-time insights, delivered directly into the clinician’s workflow, drive measurable clinical and financial outcomesSAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV), today released key 2025 highlights. The past year was defined by continued publication of research demonstrat ...
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
Globenewswire· 2025-10-30 20:30
Core Insights - Counterpart Health has released a whitepaper demonstrating how its Counterpart Assistant (CA) technology enhances value-based care in resource-constrained primary care settings, particularly in high Area Deprivation Index (ADI) neighborhoods [1][2] Group 1: Diagnosis and Early Detection - Patients from socioeconomically disadvantaged neighborhoods attributed to a CA primary care provider (PCP) showed significantly higher diagnosis rates for chronic diseases in their first year after enrollment, with increases of 75% for diabetes, 89% for chronic kidney disease (CKD), 89% for chronic heart failure (CHF), and 70% for chronic obstructive pulmonary disease (COPD) [3] - CKD and diabetes patients were diagnosed at earlier clinical stages, with CKD patients showing initial markers at Stage 2 on average, compared to Stage 3A, and diabetes patients having average A1C levels of 6.8% versus 7.1% in the comparison group [4] Group 2: Care Utilization and Outcomes - CA PCP attribution was linked to a significant reduction in acute care utilization, with all-cause inpatient hospitalizations decreasing by 7.6% to 21.2% and 30-day readmissions dropping by 11.5% to 20.8% across the four chronic diseases studied [5] - The whitepaper emphasizes that early detection allows for timely interventions, potentially altering disease trajectories in communities burdened by chronic diseases [6] Group 3: Technology and Infrastructure - The CA technology integrates AI-powered clinical insights into workflows, enabling clinicians to identify high-risk patients and intervene earlier without increasing administrative burdens, thus facilitating proactive care in resource-constrained practices [7] - Counterpart Health aims to extend its data-driven technology platform beyond Clover Health's Medicare Advantage plan to improve patient outcomes and reduce healthcare costs nationwide [8]